Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas

Sandrine Aspeslagh, Mark Stein, Rastilav Bahleda, Antoine Hollebecque, Gilles Salles, Emmanuel Gyan, Salvador Fudio, Sonia Extremera, Vicente Alfaro, Arturo Soto-Matos, Jean-Charles Soria

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas'. Together they form a unique fingerprint.

Medicine & Life Sciences